Literature DB >> 2427255

Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans.

H Bisgaard, P Olsson, M Bende.   

Abstract

The possible role of leukotriene D4 (LTD4) in nasal allergy was investigated in healthy volunteers. Nasal blood flow, nasal airway resistance, nasal discharge and nasal itching and sneezing were examined. LTD4 was found to induce a dose-response related increase in nasal mucosal blood flow as measured by laser-Doppler flowmetry. Histamine exhibited similar effects on blood flow in the same concentration range. Nasal airway resistance as recorded by rhinomanometry, increased in a dose-related manner after topical LTD4. Nasal secretion was obtained by nasal lavage and estimated from a dilution principle. Topical LTD4 did not increase the amount of nasal secretion, whereas a dose-related increase was found after topical histamine. LTD4 did not cause itching, sneezing or other irritative symptoms. In conclusion, LTD4 may play a role in nasal allergy by increasing blood flow and nasal airway resistance. Itching, sneezing and discharge, however, are apparently not caused by LTD4 but can be accounted for by the release of histamine or other mediators.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427255     DOI: 10.1111/j.1365-2222.1986.tb01960.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  14 in total

Review 1.  The role of leukotrienes and antileukotriene agents in the pathogenesis and treatment of allergic rhinitis.

Authors:  R A Simon
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Leukotriene D4 increases the excitability of capsaicin-sensitive nasal sensory nerves to electrical and chemical stimuli.

Authors:  T E Taylor-Clark; C Nassenstein; B J Undem
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

3.  Effects of leukotriene D4 nasal challenge on bronchial responsiveness and inflammation in asthmatic patients with allergic rhinitis.

Authors:  Zheng Zhu; Yanqing Xie; Weijie Guan; Yi Gao; Rongquan Huang; Shu Xia; Wenhua Jian; Zhiyu Liang; Jinping Zheng
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

Review 4.  Viral rhinitis.

Authors:  D A Gentile; D P Skoner
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.806

Review 5.  Antileukotrienes in upper airway inflammatory diseases.

Authors:  Cemal Cingi; Nuray Bayar Muluk; Kagan Ipci; Ethem Şahin
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

6.  Leukotriene D4 nasal provocation test: Rationale, methodology and diagnostic value.

Authors:  Zheng Zhu; Yanqing Xie; Weijie Guan; Y I Gao; Shu Xia; Jianxin Liang; Jinping Zheng
Journal:  Exp Ther Med       Date:  2016-05-10       Impact factor: 2.447

7.  Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.

Authors:  Daniel K C Lee; Catherine M Jackson; Patricia C Soutar; Thomas C Fardon; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

Review 8.  Montelukast in pediatric asthma management.

Authors:  Mandeep Walia; Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2006-04       Impact factor: 1.967

Review 9.  Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.

Authors:  M Peters-Golden; M M Gleason; A Togias
Journal:  Clin Exp Allergy       Date:  2006-06       Impact factor: 5.018

10.  A pilot study of an in-vitro bovine trachea model of the effect of continuous positive airway pressure breathing on airway surface liquid.

Authors:  David E White; Roy J Nates; Jim Bartley
Journal:  Biomed Eng Online       Date:  2014-02-06       Impact factor: 2.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.